Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1675
    +0.0018 (+0.16%)
     
  • GBP/USD

    1.2487
    -0.0024 (-0.19%)
     
  • Bitcoin GBP

    51,054.42
    -574.73 (-1.11%)
     
  • CMC Crypto 200

    1,323.61
    -72.93 (-5.22%)
     
  • S&P 500

    5,111.79
    +63.37 (+1.26%)
     
  • DOW

    38,297.45
    +211.65 (+0.56%)
     
  • CRUDE OIL

    83.82
    +0.25 (+0.30%)
     
  • GOLD FUTURES

    2,349.70
    +7.20 (+0.31%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Vistin Pharma ASA : Call for annual general meeting

Oslo, Norway, 28 April 2021

Vistin Pharma ASA (OSE: VISTIN), please find attached the call for the Annual General Meeting in Vistin Pharma, to be held on 20 May at 13:00 CEST. Due to the Covid-19 situation, a physical Annual General Meeting cannot be held. Instead, shareholders should authorize the Chairman of the Board. It is possible to give proxy with and without voting instructions. By using a proxy with voting instructions, the shareholders will vote on the specific issues without personal attendance. For further information on the use of proxy, see general information at the bottom of the notice and enclosed proxy forms.

The recommendation from the Election Committee is available on the Company's website. The formal call will be sent to all shareholders registered in the Norwegian Central Security Depository (VPS) and are also attached to this announcement.

For further information, please contact:

ADVERTISEMENT

Alexander Karlsen
CFO
+47 97 05 36 21
alexander.karlsen@vistin.com

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Attachment